MAPT and brain disorder: After obtaining RNA or protein expression using sequencing and mass spectrometry, in some cases, features selected through a feature selection step are used, and clinical features related to patients such as sex, age, and behavioral score, etc., and there are also studies using machine learning by quantifying known brain disease-related proteins such as aβ, α-synuclein, and tau, etc. by immunocapture assay.